tokens: Patients with advanced ovarian carcinoma , Stage III or IV ( International Federation of Gynaecology and Obstetrics ) , were randomized to primary chemotherapy with doxorubicin ( Adriamycin ) and cisplatin plus or minus hexamethylmelamine , and cyclophosphamide ( CHAP ) .